Kalmar Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $7.85M | Sell |
118,827
-274,057
| -70% | -$18.1M | 1.77% | 12 |
|
|
2016
Q4 | $24.9M | Sell |
392,884
-48,045
| -11% | -$3.05M | 1.28% | 18 |
|
|
2016
Q3 | $28.1M | Sell |
440,929
-6,813
| -2% | -$434K | 1.28% | 20 |
|
|
2016
Q2 | $33.3M | Sell |
447,742
-4,418
| -1% | -$329K | 1.47% | 18 |
|
|
2016
Q1 | $30.2M | Sell |
452,160
-17,745
| -4% | -$1.19M | 1.24% | 26 |
|
|
2015
Q4 | $31.8M | Sell |
469,905
-19,207
| -4% | -$1.3M | 0.78% | 54 |
|
|
2015
Q3 | $26.1M | Sell |
489,112
-77,726
| -14% | -$4.15M | 0.61% | 65 |
|
|
2015
Q2 | $35.7M | Sell |
566,838
-130,116
| -19% | -$8.19M | 0.68% | 60 |
|
|
2015
Q1 | $33.5M | Buy |
696,954
+233,839
| +50% | +$11.2M | 0.62% | 65 |
|
|
2014
Q4 | $15.4M | Buy |
+463,115
| New | +$15.4M | 0.29% | 107 |
|